Clinical Data

heart over ekg

Biotech

Ventyx's CV drug rapidly reduces cardio risk biomarker

Ventyx Biosciences’ cardiovascular disease drug cut levels of a biomarker for stroke and other serious risks by almost 80% within a week.

James Waldron Oct 23, 2025 9:45am

Cytomegalovirus CMV herpes herpesvirus virus

Moderna scraps congenital virus program after vax fails ph. 3

Oct 22, 2025 5:15pm

Wall Street IPO initial public offering markets shares stock

Arcturus' stock halves on cystic fibrosis readout

Oct 22, 2025 1:01pm

brain

Alector halves staff after GSK-partnered antibody fails in ph. 3

Oct 22, 2025 11:23am

On target clinical trial success bullseye score

Sanofi's $1.7B bet beats CSL's Zemaira in phase 2 face-off

Oct 22, 2025 10:35am

Make a delay and accumulation of outstanding tasks Full stop

Terns mothballs obesity program after phase 2 data fall short

Oct 22, 2025 7:15am